Desentum
Therapeutics & Diagnostics · Espoo
Allergy immunotherapy: engineered recombinant allergens for faster, safer desensitisation (birch, peanut, cat). Products in development.
Pre-revenue📍 Espoo📅 Founded 2011🎓 VTT + UEF
The row
- Stage
- Pre-revenue — No sales yet
- Location
- Espoo
- Founded
- 2011
- Research origin
- VTT + UEF
- Business ID
- 2425894-6 · Finnish trade register
- Funding
- €18M share issue (3–4/2026) + €12M (2/2024) + €8M (1/2022), all arranged by Springvest for Finnish private investors and family offices; two earlier Springvest issues are not itemised
Links
Where this sits on the map
Desentum is one of 33 companies in Therapeutics & Diagnostics. The others:
How this row was decided
Every row on this map is checked by hand against the trade register and the company's own material, and placed in the sector that best describes its business or its technology. Service firms and consultancies are left out, however advanced the technology they work with — the test is where the revenue comes from. Only funding figures the company or its investor has published are shown. The full rules are on the landscape ↗